gr 144053 has been researched along with eptifibatide in 3 studies
Studies (gr 144053) | Trials (gr 144053) | Recent Studies (post-2010) (gr 144053) | Studies (eptifibatide) | Trials (eptifibatide) | Recent Studies (post-2010) (eptifibatide) |
---|---|---|---|---|---|
21 | 1 | 2 | 907 | 220 | 212 |
Protein | Taxonomy | gr 144053 (IC50) | eptifibatide (IC50) |
---|---|---|---|
Integrin beta-3 | Homo sapiens (human) | 0.226 | |
Integrin alpha-IIb | Homo sapiens (human) | 0.226 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gretler, DD; Scarborough, RM | 1 |
Heptinstall, S; Storey, RF; Wilcox, RG | 1 |
Rozalski, M; Watala, C | 1 |
1 review(s) available for gr 144053 and eptifibatide
Article | Year |
---|---|
Platelet glycoprotein IIb-IIIa antagonists as prototypical integrin blockers: novel parenteral and potential oral antithrombotic agents.
Topics: Administration, Oral; Animals; Antibodies, Monoclonal; Clinical Trials as Topic; Drug Design; Fibrinolytic Agents; Humans; Injections; Integrins; Molecular Mimicry; Peptides; Platelet Glycoprotein GPIIb-IIIa Complex; Snake Venoms | 2000 |
1 trial(s) available for gr 144053 and eptifibatide
Article | Year |
---|---|
Differential effects of glycoprotein IIb/IIIa antagonists on platelet microaggregate and macroaggregate formation and effect of anticoagulant on antagonist potency. Implications for assay methodology and comparison of different antagonists.
Topics: Adenosine Diphosphate; Anticoagulants; Citrates; Collagen; Eptifibatide; Hirudins; Humans; Nephelometry and Turbidimetry; Oligopeptides; Peptides; Peptides, Cyclic; Piperazines; Piperidines; Platelet Aggregation Inhibitors; Platelet Count; Platelet Glycoprotein GPIIb-IIIa Complex; Sodium Citrate; Thiazolidines | 1998 |
1 other study(ies) available for gr 144053 and eptifibatide
Article | Year |
---|---|
Antagonists of platelet fibrinogen receptor are less effective in carriers of Pl(A2) polymorphism of beta(3) integrin.
Topics: Adult; Eptifibatide; Female; Genotype; Humans; Integrin beta3; Intercellular Signaling Peptides and Proteins; Male; Nephelometry and Turbidimetry; Peptides; Piperazines; Piperidines; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Polymorphism, Genetic; Receptors, Fibrinogen | 2002 |